Showing 101 - 120 results of 37,199 for search '(( significant progressive decrease ) OR ( significant interaction (decrease OR increase) ))', query time: 1.47s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105
  6. 106
  7. 107

    DataSheet2_Nicotinamide Mononucleotide Alleviates LPS-Induced Inflammation and Oxidative Stress via Decreasing COX-2 Expression in Macrophages.docx by Jing Liu (38537)

    Published 2021
    “…Quantitative proteomics identified that nicotinamide mononucleotide downregulated the expressions of LPS-responsive proteins, in which cyclooxygenase-2 (COX-2) expression was significantly decreased in NMN-treated cells. Consequently, the cellular levels of prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) was also decreased, indicating that NMN inactivated macrophages via COX-2-PGE<sub>2</sub> pathway, which was validated in activated THP-1 cells and mouse peritoneal macrophages. …”
  8. 108

    DataSheet1_Nicotinamide Mononucleotide Alleviates LPS-Induced Inflammation and Oxidative Stress via Decreasing COX-2 Expression in Macrophages.xlsx by Jing Liu (38537)

    Published 2021
    “…Quantitative proteomics identified that nicotinamide mononucleotide downregulated the expressions of LPS-responsive proteins, in which cyclooxygenase-2 (COX-2) expression was significantly decreased in NMN-treated cells. Consequently, the cellular levels of prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) was also decreased, indicating that NMN inactivated macrophages via COX-2-PGE<sub>2</sub> pathway, which was validated in activated THP-1 cells and mouse peritoneal macrophages. …”
  9. 109

    S1 Data - by Hao Deng (409186)

    Published 2024
    Subjects:
  10. 110
  11. 111
  12. 112
  13. 113
  14. 114

    FASN Expression in OA and RA–shows that FASN is also significantly downregulated in the disease groups for OA and RA, suggesting its decreased activity might influence disease mechanisms or progression. by Chang-sheng Liao (18591969)

    Published 2024
    “…<p>FASN Expression in OA and RA–shows that FASN is also significantly downregulated in the disease groups for OA and RA, suggesting its decreased activity might influence disease mechanisms or progression.…”
  15. 115
  16. 116
  17. 117
  18. 118
  19. 119
  20. 120